CM Life Sciences III Inc.

CM Life Sciences III Inc. (Nasdaq: CMLT) is a blank-check company sponsored by CM Life Sciences, a partnership backed by Cornell Capital and MSD Partners, focused on identifying targets in the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and, as of a definitive merger proxy filing submitted to the SEC on September 29, 2023, was in the shareholder-approval stage of a proposed business combination. The DEFM14A filing, assigned accession number 0001193125-23-247498, signals that the transaction had advanced to the final vote stage. Sign up at SpacDesk for full filing history, deal terms, and real-time status updates on CMLT and hundreds of other active SPACs.